Cargando…
853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study
BACKGROUND: Vancomycin-Resistant Enterococcus (VRE) is considered one of the main pathogens of hospital-acquired infections (HAI), responsible for high morbidity and mortality rates. HAI caused by this bacteria, especially in intensive care units (ICU), are concerning for the health system, given th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776628/ http://dx.doi.org/10.1093/ofid/ofaa439.1042 |
_version_ | 1783630727538016256 |
---|---|
author | Tanure, Luciana Coelho Pinho, Rafaela Tonholli Alves, Érico Macedo Pacheco Pires, Bárbara Caldeira Lopes, Joice Ribeiro Ribeiro, Daniela Teixeira de Souza, Flávio Henrique Batista Couto, Braulio Roberto Gonçalves Marinho Starling, Carlos Ernesto Ferreira |
author_facet | Tanure, Luciana Coelho Pinho, Rafaela Tonholli Alves, Érico Macedo Pacheco Pires, Bárbara Caldeira Lopes, Joice Ribeiro Ribeiro, Daniela Teixeira de Souza, Flávio Henrique Batista Couto, Braulio Roberto Gonçalves Marinho Starling, Carlos Ernesto Ferreira |
author_sort | Tanure, Luciana Coelho |
collection | PubMed |
description | BACKGROUND: Vancomycin-Resistant Enterococcus (VRE) is considered one of the main pathogens of hospital-acquired infections (HAI), responsible for high morbidity and mortality rates. HAI caused by this bacteria, especially in intensive care units (ICU), are concerning for the health system, given that the microorganism is multi resistant to most antimicrobials available, especially vancomycin. Therefore, the present study is built from and analyzes the data of VRE, collected by the Infection Prevetion and Control Service of hospitals in Brazil, to clarify: the incidence rate, the gross lethality of these infections and what are the profiles of infected patients. METHODS: Collection and analysis of epidemiological data, according to the National Healthcare Safety Network (NHSN) protocol of the Centers for Disease Control and Prevention (CDC), in 10 hospitals in Brazil, between Jan/2017 - Dec/2019. RESULTS: In three years, 118 VRE infections were diagnosed in the hospitals analyzed: 51 from ICU (43%), 24 from Vascular Acess (20%), 18 from General Clinic (15%), 10 from General Surgery (8%) and 15 from Others (13%). Patients ages ranged from 0 to 93 years, with a mean of 62 years (standard deviation of 20 years) and a median of 66 years. Time between admission and diagnosis of infection was 1 to 1001 days, with a mean of 68 days (standard deviation of 25 days) and a median of 59 days. The gross lethality for VRE infections was 47/118 (40%). The infection sites were: Bloodstream Infections – BSI = 34 (29%); Urinary Tract Infections – UTI = 28 (24%); Surgical Site Infections – SSI = 27 (23%); Skin and Soft Tissue Infections – SST = 14 (12%); Bone and Joint Infections – BJ = 5 (4%); Cardiovascular System Infections – CVS = 5 (4%); Lower Respiratory System Infections, other than pneumonia – LRI = 2 (2%); Pneumonia – PNEU = 2 (2%) and Gastrointestinal System Infections – GI = 1 (1%). Percentage of VRE infections by hospital units [Image: see text] Percentage of VRE infections by infection sites [Image: see text] Infection sites of VRE infections by hospital [Image: see text] CONCLUSION: VRE infection is a highly lethal event that usually occurs after two months of hospitalization. The main site of infection is the BSI, with a higher incidence in patients over 62 years or the ones in ICU. Early and accurate investigations of multiresistant microorganisms in a hospital setting are necessary to reduce patient morbidity and mortality. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-7776628 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77766282021-01-07 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study Tanure, Luciana Coelho Pinho, Rafaela Tonholli Alves, Érico Macedo Pacheco Pires, Bárbara Caldeira Lopes, Joice Ribeiro Ribeiro, Daniela Teixeira de Souza, Flávio Henrique Batista Couto, Braulio Roberto Gonçalves Marinho Starling, Carlos Ernesto Ferreira Open Forum Infect Dis Poster Abstracts BACKGROUND: Vancomycin-Resistant Enterococcus (VRE) is considered one of the main pathogens of hospital-acquired infections (HAI), responsible for high morbidity and mortality rates. HAI caused by this bacteria, especially in intensive care units (ICU), are concerning for the health system, given that the microorganism is multi resistant to most antimicrobials available, especially vancomycin. Therefore, the present study is built from and analyzes the data of VRE, collected by the Infection Prevetion and Control Service of hospitals in Brazil, to clarify: the incidence rate, the gross lethality of these infections and what are the profiles of infected patients. METHODS: Collection and analysis of epidemiological data, according to the National Healthcare Safety Network (NHSN) protocol of the Centers for Disease Control and Prevention (CDC), in 10 hospitals in Brazil, between Jan/2017 - Dec/2019. RESULTS: In three years, 118 VRE infections were diagnosed in the hospitals analyzed: 51 from ICU (43%), 24 from Vascular Acess (20%), 18 from General Clinic (15%), 10 from General Surgery (8%) and 15 from Others (13%). Patients ages ranged from 0 to 93 years, with a mean of 62 years (standard deviation of 20 years) and a median of 66 years. Time between admission and diagnosis of infection was 1 to 1001 days, with a mean of 68 days (standard deviation of 25 days) and a median of 59 days. The gross lethality for VRE infections was 47/118 (40%). The infection sites were: Bloodstream Infections – BSI = 34 (29%); Urinary Tract Infections – UTI = 28 (24%); Surgical Site Infections – SSI = 27 (23%); Skin and Soft Tissue Infections – SST = 14 (12%); Bone and Joint Infections – BJ = 5 (4%); Cardiovascular System Infections – CVS = 5 (4%); Lower Respiratory System Infections, other than pneumonia – LRI = 2 (2%); Pneumonia – PNEU = 2 (2%) and Gastrointestinal System Infections – GI = 1 (1%). Percentage of VRE infections by hospital units [Image: see text] Percentage of VRE infections by infection sites [Image: see text] Infection sites of VRE infections by hospital [Image: see text] CONCLUSION: VRE infection is a highly lethal event that usually occurs after two months of hospitalization. The main site of infection is the BSI, with a higher incidence in patients over 62 years or the ones in ICU. Early and accurate investigations of multiresistant microorganisms in a hospital setting are necessary to reduce patient morbidity and mortality. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776628/ http://dx.doi.org/10.1093/ofid/ofaa439.1042 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Abstracts Tanure, Luciana Coelho Pinho, Rafaela Tonholli Alves, Érico Macedo Pacheco Pires, Bárbara Caldeira Lopes, Joice Ribeiro Ribeiro, Daniela Teixeira de Souza, Flávio Henrique Batista Couto, Braulio Roberto Gonçalves Marinho Starling, Carlos Ernesto Ferreira 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study |
title | 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study |
title_full | 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study |
title_fullStr | 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study |
title_full_unstemmed | 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study |
title_short | 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study |
title_sort | 853. hospital-acquired infections by vancomycin-resistant enterococcus (vre): results in 3 years of multicenter study |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776628/ http://dx.doi.org/10.1093/ofid/ofaa439.1042 |
work_keys_str_mv | AT tanurelucianacoelho 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy AT pinhorafaelatonholli 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy AT alvesericomacedopacheco 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy AT piresbarbaracaldeira 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy AT lopesjoiceribeiro 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy AT ribeirodanielateixeira 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy AT desouzaflaviohenriquebatista 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy AT coutobrauliorobertogoncalvesmarinho 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy AT starlingcarlosernestoferreira 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy |